Manufacturing Execution System Market

Incorporation of MES into production line can streamline material cost and time spent in production. I believe, MES has the potential to reduce 10%-30% of the overall production cost, depending on the type of industry

-- CEO, a small-sized company

Manufacturing Execution System Market Size Overview

The manufacturing execution system market, valued at USD 4.62 billion in 2025, is projected to grow to USD 5.36 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 16.0% during the forecast period.
The market for manufacturing execution systems (MES) is projected to grow vigorously with several driving factors. However, the rising complexity in the manufacturing process of biologics and pharmaceuticals is one of the leading factors to accelerate the growth of the market.

To learn more about this report, request a free sample copy

Over the years, constantly growing shortages of manpower in the healthcare sector combined with expanding data have fabricated immense opportunities for innovative tools & technologies to overcome the excess pressure on the healthcare industry in production process management. With regard to this, the manufacturing execution system is an innovative tool that supports manufacturing operations to monitor and track production processes in real time. It connects enterprise resource planning (ERP) and supervisory control and data acquisition (SCADA) systems which help manage production processes and monitor the physical processes on the plant floor. In pharmaceutical manufacturing, electronic batch records capture the materials, process steps, checks and approvals associated with each batch.

In addition, the propelling penetration of advanced technology, particularly, industry 4.0, the rise of smart manufacturing in pharmaceutical and biologics contract manufacturing with digital transformation, and the Internet of Things (IoT) are increasingly promoting such advanced software solutions similar to MES in the healthcare industry. These emerging technologies have enabled connectivity and data exchange between machines, sensors, and systems that provide real-time monitoring, analysis, and optimization of production processes. Thereby, to leverage the growing demand for operational efficiency and integration of IoT, market players are continuously focusing on the development of smart manufacturing execution systems to enhance their product portfolio and competitive edge in the global MES market. Despite the advantages of the manufacturing execution system, the complexity of integration of MES with existing operating systems can cause challenges for the growth of the market.

Tap or click on the images for smart insights on Manufacturing Execution System Market

Manufacturing Execution System Market Segmentation Insights

The market research report presents an in-depth analysis of the various companies that are engaged in the global market of MES, across different segments, as defined in the table below:

Global Manufacturing Execution System Market: Report Attributes / Market Segmentations

Key Report Attribute	Details
Historical Trend	Since 2022
Forecast Period	Till 2035
Market Size 2026	USD 5.36 Billion
Market Size 2035	USD 20.46 Billion
CAGR (Till 2035)	16.0%
Type of Deployment	Cloud Corporate Data Center Hybrid  On Premise
Type of End-User	Life Science / Biotechnology Companies Medical Device Providers Pharmaceutical Companies and Others
Key Geographical Regions	North America Europe Asia Pacific Latin America  Middle East and North Africa
Key Companies Profiled	Andea, Critical Manufacturing  Dassault Systèmes GE Digital Infor Körber Rockwell Automation (Full list of 110+ companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Market Landscape Analysis for Manufacturing Market Landscape Analysis Partnerships and Collaborations Company Competitiveness Analysis Value Creation Framework Market Forecast and Opportunity Analysis

Tap or click on the images for smart insights on Manufacturing Execution System Market

One of the key objectives of this market report was to estimate the current market size, opportunity, and future growth potential of the manufacturing execution system market, over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period, till 2035. The market report also features the likely distribution of the current and forecasted opportunity within the MES market  across various segments, such as type of deployment (cloud, corporate data center, hybrid,  and on premise), type of end user (life science/biotechnology companies, medical device providers, pharmaceutical companies and others) and key geographical regions (North America, Europe and Asia Pacific, Latin America, Middle East, North Africa and rest of the world). 

In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the market research report were also influenced by discussions held with multiple stakeholders in manufacturing execution system market. The market report features detailed transcripts of interviews held with the following individuals:

• Chief Marketing Officer, UK based Small Company
• Chief Executive Officer, India based Mid-Sized Company
• Director of Sales, Israel based Small Company

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Tap or click on the images for smart insights on Manufacturing Execution System Market

Manufacturing Execution System Market Share Insights

Market Share by Type of Deployment

Based on the type of deployment, the MES market is split into Cloud, Corporate Datacentre, Hybrid and On Premise. In terms of market revenue, the cloud segment acquires 68.5% of the manufacturing execution system market share. The hybrid escalates the market growth at 18.62% CAGR during this forecast period. 

The growing demand for cloud-based MES solutions notably uplifts the market growth due to their flexibility, scalability, and accessibility enabling manufacturers to adjust their operations effortlessly. In addition, the seamless integration of real-time data from diverse locations enhances collaboration coupled with its decision-making capabilities and remote access functionalities. As a result, the cloud segment is poised to drive the manufacturing execution system market growth throughout the forecast period.

Market Share by Type of End User

Based on the type of end user, the global manufacturing execution system market is bifurcated into Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies, and Others. As per our projection, medical device providers dominate the end-user segment with 51 % of the market share. Life science/biotechnology companies drive the market growth with a CAGR of 16.46% and are likely to boost the market demand as these companies highly rely on MES that aid in managing batch production, tracking, and tracing materials and products. It also ensures compliance with stringent regulatory requirements and maintains data integrity.

Market Share by Key Geographical Regions

This segment highlights the distribution of the MES market across various geographies, such as North America, Europe, Asia-Pacific, Latin America, Middle East, and North Africa. As per market statistics, Europe accounts for 41% of the manufacturing execution system market share and holds the leading position in the global market for manufacturing execution systems. The early adoption of automation and strong demand for MES across various industries substantially contribute to the region’s leading position. In addition, the strong regulatory environment, the presence of European MES providers in the global marketplace, and the collaborative ecosystem contribute to flourishing market growth in Europe.

Furthermore,  Asia Pacific’s fastest-growing economy fuels the manufacturing execution systems market growth at a CAGR of 16.8%. The region's growth is projected to continue to grow due to rapid industrialization, digitization, and an upsurge in the adoption of Industry 4.0 in various sectors, specifically, in the medical sector. Additionally, the expanding pharmaceutical industries including many life science/ biotechnology companies coupled with the increased penetration of advanced technologies, is poised to augment the market growth over this projection timeframe.

Manufacturing Execution System Market: Key Insights

The “Manufacturing Execution System Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in providing MES solutions to pharmaceutical industry. Key takeaways of the market report are briefly discussed below.

Competitive Landscape of Manufacturing Execution System Market Service Providers

Presently, more than 75 small, medium, and very large companies are serving in the healthcare MES market, offering integrated MES software to manage, monitor, and control the production process in the medical sector. A diverse range of software is being offered by these companies through different licensing models to cater to the medical device industry, life science biotechnology and pharmaceutical companies. Some of the prominent companies are Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. By leveraging technological advancements, these companies are continually shaping the market dynamics. 

Global Manufacturing Execution System Market Size

The global manufacturing execution system market is estimated to be worth USD 5.36 billion in the current year. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive market growth at a CAGR of more than 16% during the forecast period.

Segment Analysis: Cloud-Based Manufacturing Execution Systems Are Witnessing Increasing Adoption

It has been observed that companies are increasingly adopting cloud-based manufacturing execution systems, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promote collaboration. In January 2024, Canada based IT Consulting company CGI Group announced collaboration with Korber for leveraging its Werum PAS-X MES Suite to serve its pharmaceutical clients. This MES suite is specifically developed for pharmaceutical and biotechnology industry and is available as either on-premise or cloud-based solution.

Trends Analysis in Manufacturing Execution System Market: Integration of MES with Quality Management System Widen Market Prospect

In recent years, with the mounting penetration of technological advancements, the market for manufacturing execution systems has been evolving exponentially. The trend of integrated quality management systems is one of the latest trends in the manufacturing execution system industry. This integrated MES with quality management system is gaining traction due to its advantages in streamlining compliance with regulatory standards such as ISO 13485 and FDA regulations for instance 21 CFR Part 820 for medical devices which allows companies to report, monitor, and traceability of quality-related data throughout the product lifecycle. Along with this, cloud-based manufacturing execution systems are gaining strong demand in the healthcare sector that facilitate manufacturing control from any location, and offer remote collaboration, decision-making, and compliance management. These cloud-based MES solutions are specifically suitable for global supply chains and distributed manufacturing networks.

Manufacturing Execution System Market Drivers: Cost Saving Potential and Rising Adoption

According to industry experts, manufacturing execution systems have the potential to reduce 10%-30% of the overall production cost depending on the type of industry. Total Lab Automation connects sample handling, analytical instruments and laboratory informatics within a coordinated workflow. In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. Both the contract manufacturing and in-house manufacturing facilities are adopting industry 4.0 technologies. These technologies are allowing digital manufacturing of therapeutics and vaccines. Within this workflow, digital biomanufacturing connects process data, automation and analytics to improve control of biopharmaceutical production.

BioNTech collaborated with Siemens for making its Marburg, Germany facility Industry 4.0 compatible. The facility was one of the main sites for production of its COVID-19 vaccine, belonging to mRNA vaccine and therapeutics market. The company adopted Siemens’ Opcenter Execution Pharma solution as the new MES to allow paperless manufacturing.

Key Players in Manufacturing Execution System Market 

Examples of key companies engaged in the manufacturing execution system industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. This market report includes an easily searchable excel database of all the companies who are providing and have adopted the manufacturing execution systems in pharmaceutical industry.

Manufacturing Execution System Market Report Coverage

• An outline of the systematic research methodology adopted to conduct the study on manufacturing execution system providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
• An executive summary of the key insights captured during our research, offering a high-level view on the current landscape of the manufacturing execution systems and companies their likely evolution in the short to mid and long term.
• A general introduction to manufacturing execution systems, along with information on their core functions. Additionally, it includes details on the various deployment models adopted by providers. Further, it features a brief discussion on the key advantages and disadvantages associated with manufacturing execution systems in the healthcare sector.
• A detailed overview of the current market landscape of manufacturing execution system companies in the healthcare industry, along with information on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters (North America, Europe and Asia), type of deployment (cloud, corporate datacenter, hybrid and on premise), integrating MES software (enterprise resource planning, human resource management, manufacturing operation management and product lifecycle management), type of license (perpetual, subscription), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), key features (data integration, document control, performance analysis, production tracking), type of service(s) offered (general support, implementation / upgradation, training) and quality certifications received (ISA-95, ISA-88, ISO 9001, ISO 14001, ISO 13485).
• An in-depth analysis, highlighting the contemporary manufacturing execution system market trends using five schematic representations, including [A] a vertically grouped bar chart, based on year of establishment and region of headquarters, [B] a horizontally stacked bar chart, based on company size and type of deployment, [C] a waffle chart representation, based on type of license and end-user, [D] a mekko chart representation, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in MES market, based on several relevant parameters (such as year of establishment, company size, deployment type and quality certifications).
• An analysis of the partnerships that have been established in  manufacturing execution system market  since 2018, covering instances of acquisition, clinical trial agreement, commercialization agreement, distribution agreement, antibody manufacturing agreement, product development agreement, product development and commercialization agreement, research and development agreement, supply agreement and other relevant type of deals.
• An analysis of big pharma players engaged in the field of  manufacturing execution system market , featuring various insightful representations, such as spider web analysis, Harvey ball analysis and wind rose chart, based on several relevant parameters, such as number of therapeutics under development, type of novel antibody, status of development, number of target indications, number of partnerships, number of patents and years of experience.
• An analysis of recent partnerships inked between various stakeholders engaged in manufacturing execution system market, since 2018, based on several relevant parameters, such as year of partnership, type of partnership model adopted (acquisitions, distribution agreements, service agreements, service alliances, technology integration agreements and technology utilization agreements), type of partner (automation industry, biotechnology, information technology and others), key players (in terms of number of partnerships) and regional distribution.
• An insightful competitiveness analysis of manufacturing execution system providers in the healthcare industry based on several relevant parameters, such as product portfolio strength (in terms of years of experience of the packaging provider), competitive index (in terms of type of deployment, type of license, type of end-user, key features, type of service(s) offered and quality certifications) and partnership strength (taking into consideration the number of partnerships and type of agreement).
• Elaborate profiles of key players engaged in the manufacturing execution system industry. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters and key executives, recent developments and an informed future outlook.
• An insightful framework depicting the implementation of several advanced tools and technologies, such as artificial intelligence, cloud computing, internet of things and machine learning, in different production stages / functions, which can assist service providers in addressing existing unmet needs. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating above-mentioned technologies, based on the trends highlighted in published literature and patents.
• A detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for manufacturing execution system market during the forecast period. Additionally, the market report features the likely distribution of the current and forecasted opportunity across type of deployment (cloud, corporate datacenter, hybrid and on premise), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), and key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World). In order to account for future uncertainties and add robustness to our forecast model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Recent Developments In Manufacturing Execution System Market

Several recent developments have taken place in the field of manufacturing execution systems. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In June 2025, Honeywell announced the acquisition of Sundyne in order to enhance its process industry capabilities including manufacturing execution systems through Sundyne's centrifugal pump technologies for improved operational efficiency in chemical and pharma sectors.
• In February 2025, Yokogawa released OpreX Quality Management System integrated with MES functionalities to accelerate digital transformation in pharmaceutical manufacturing, ensuring regulatory compliance, real-time quality control, and operational efficiency.